Skip to main content

Table 1 Baseline characteristics of participants in the CIMWM and TMWM groupsa

From: Effectiveness of companion-intensive multi-aspect weight management in Chinese adults with obesity: a 6-month multicenter randomized clinical trial

  CIMWM TMWM p valueb
Age (years) 31.52 ± 6.43 32.16 ± 6.39 0.427
Sex (M/F) 72/51 77/54 0.969
BMI (kg/m2) 32.36 ± 3.40 32.48 ± 3.59 0.800
BW (kg) 92.77 ± 14.91 92.98 ± 14.08 0.909
BFP (%) 34.60 ± 4.54 35.03 ± 4.72 0.459
BFM (kg) 32.03 ± 6.32 32.61 ± 7.06 0.490
FFM (kg) 60.82 ± 11.14 60.30 ± 9.88 0.689
SMM (kg) 33.30 ± 6.20 33.07 ± 5.49 0.752
VFA (cm2) 133.70 ± 34.46 140.5 ± 48.59 0.205
S/V (kg/cm2) 0.26 ± 0.08 0.27 ± 0.23 0.760
WC (cm) 103.59 ± 11.78 103.70 ± 12.74 0.940
HC (cm) 110.61 ± 7.58 110.34 ± 11.86 0.832
WHR 0.94 ± 0.09 0.99 ± 0.69 0.365
SBP (mmHg) 130.88 ± 12.79 131.73 ± 13.64 0.607
DBP (mmHg) 82.66 ± 10.22 83.75 ± 10.70 0.409
ALT (U/L) 44.79 ± 37.24 38.36 ± 26.57 0.113
AST (U/L) 27.98 ± 14.08 26.02 ± 11.46 0.224
TC (mmol/L) 5.15 ± 1.05 5.09 ± 0.84 0.574
TG (mmol/L) 2.16 ± 1.70 1.98 ± 1.12 0.307
HDL-C (mmol/L) 1.11 ± 0.27 1.22 ± 1.16 0.296
LDL-C (mmol/L) 3.19 ± 0.74 3.17 ± 0.71 0.839
Lp (a) (mg/L) 158.20 ± 172.72 140.05 ± 145.57 0.365
FPG (mmol/L) 5.16 ± 0.75 5.13 ± 1.08 0.763
Cr (µmol/L) 70.25 ± 15.70 67.57 ± 15.71 0.176
UA (µmol/L) 404.12 ± 111.32 389.11 ± 116.72 0.296
FINS (pmol/L) 157.82 ± 198.46 135.32 ± 80.83 0.233
FCP (pmol/L) 1292.20 ± 1201.69 1062.05 ± 454.12 0.048*
HbA1c (%) 5.51 ± 0.42 5.48 ± 0.37 0.516
IFG Number (%) 11(8.9%) 10(7.6%) 0.705
PLT (×109) 267.80 ± 56.57 261.10 ± 60.25 0.363
ALB (g/L) 45.90 ± 4.26 45.48 ± 3.96 0.418
NFS − 3.12 ± 1.01 − 2.91 ± 1.07 0.111
Fibrosis Severity Scale    0.126
 F0–F2 119(96.7%) 121(92.4%)
 Indeterminant score 4(3.3%) 10(7.6%)
 F3–F4 0 0
HOMA-IR 5.16 ± 6.15 4.42 ± 2.78 0.209
  1. BMI Body mass index, BW body weight, BFP body fat percentage, BFM body fat mass, FFM fat-free mass, SMM skeletal muscle mass, VFA visceral fat area, S/V skeletal muscle mass-to-visceral fat area radio, WC waist circumference, HC hip circumference, WHR waist-to-hip ratio, ALT alanine aminotransferase, AST aspartate aminotransferase, TC total cholesterol, TG triglyceride, HDL⁃C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, [Lp(a)] Lipoprotein(a), Cr creatinine, UA uric acid, FPG fasting plasma glucose, FINS fasting insulin, FCP fasting C peptide, PLT platelet, ALB albumin, HbA1c glycated hemoglobin, NFS non-alcoholic fatty liver disease score, IFG impaired fasting glucose, SBP systolic blood pressure, DBP diastolic blood pressure, HOMA-IR homeostasis model assessment of insulin resistance
  2. aData are represented as mean ± SD for continuous variables and as percentages for categorical variables
  3. bIndependent samples t test and chi-square test were used for continuous and categorical variables, respectively
  4. *p < 0.05
\